Role of inflammation in the pathogenesis of diabetic retinopathy
- PMID: 22346117
- PMCID: PMC3277027
- DOI: 10.4103/0974-9233.92118
Role of inflammation in the pathogenesis of diabetic retinopathy
Abstract
Diabetic retinopathy (DR) remains a major cause of worldwide preventable blindness. The microvasculature of the retina responds to hyperglycemia through a number of biochemical changes, including activation of protein kinase C, increased advanced glycation end products formation, polyol pathway, and oxidative stress, and activation of the renin angiotensin system (RAS). There is an accumulating body of evidence that inflammation plays a prominent role in the pathogenesis of DR.
Keywords: Angiogenesis; diabetic retinopathy; inflammation.
Conflict of interest statement
References
-
- Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2003;26:226–9. - PubMed
-
- van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) Angiogenesis. 2008;11:91–9. - PubMed
-
- Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450–2. - PubMed
-
- Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30:65–84. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
